Influence of redox-active compounds and PXR-activators on human MRP1 and MRP2 gene expression.

Article Details

Citation

Kauffmann HM, Pfannschmidt S, Zoller H, Benz A, Vorderstemann B, Webster JI, Schrenk D

Influence of redox-active compounds and PXR-activators on human MRP1 and MRP2 gene expression.

Toxicology. 2002 Feb 28;171(2-3):137-46.

PubMed ID
11836020 [ View in PubMed
]
Abstract

In the present study, we investigated the inducibility of the drug conjugate transporter genes MRP1 and MRP2 by redox-active compounds such as tertiary butylated hydroquinone (tBHQ) and quercetin and by chemicals known to activate the pregnane X receptor (PXR) such as rifampicin and clotrimazol and by the metalloid compound arsenite. The human MRP2 gene was found to be inducible in HepG2 cells by rifampicin, clotrimazol, arsenite and tBHQ. As MRP1 expression is extremely low in HepG2 cells, its inducibility was studied in MCF-7 cells. However, only tBHQ and quercetin acted as inducers, but not the other compounds investigated. Reporter gene assays demonstrated that proximal promoter regions of the genes contribute to the induction by tBHQ, quercetin (MRP1) and clotrimazol (MRP2). However, the deletion of binding sites supposed to mediate the induction process (a PXR-binding element-like sequence for the clotrimazol effect and an ARE (antioxidative response element) for the tBHQ/quercetin effect) did not result in a significant decrease in the induction factor indicating that other parts of the promoter are probably involved in the induction process. In summary, expression of both genes can be up-regulated by redox-active compounds, while the other compounds tested induced only MRP2 but not MRP1 expression.

DrugBank Data that Cites this Article

Drug Transporters
DrugTransporterKindOrganismPharmacological ActionActions
Arsenic trioxideCanalicular multispecific organic anion transporter 1ProteinHumans
Unknown
Inducer
Details
QuercetinMultidrug resistance-associated protein 1ProteinHumans
Unknown
Inhibitor
Inducer
Details
RifampicinCanalicular multispecific organic anion transporter 1ProteinHumans
Unknown
Inducer
Details
Pharmaco-transcriptomics
DrugDrug GroupsGeneGene IDChangeInteractionChromosome
ClotrimazoleApproved Vet ApprovedABCC21244
upregulated
Clotrimazole results in increased expression of ABCC2 mRNA10q24.2
QuercetinExperimental InvestigationalABCC14363
upregulated
Quercetin results in increased expression of ABCC1 mRNA16p13.11
RifampicinApprovedABCC21244
upregulated
Rifampin results in increased expression of ABCC2 mRNA10q24.2